| ACC |
American College of Cardiology |
| ACG |
American College of Gastroenterology |
| ACR |
American College of Rheumatology |
| ACS |
Acute Coronary Syndrome |
| ADE |
Adverse Drug Event |
| ADL |
Activities of Daily Living |
| ADWE |
Adverse Drug Withdrawal Event |
| AF |
Atrial Fibrillation |
| AFF |
Atypical Femoral Fracture |
| AGREE II |
Appraisal of Guidelines for Research and Evaluation II |
| AHA |
American Heart Association |
| AIMS |
Abnormal Involuntary Movement Scale |
| ASPREE |
ASPirin in Reducing Events in the Elderly |
| ATC |
Anatomical Therapeutic Chemical (Classification System) |
| AV |
Atrioventricular |
| BMD |
Bone Mineral Density |
| BP |
Blood Pressure |
| BPH |
Benign Prostatic Hyperplasia |
| BPRS |
Brief Psychiatric Rating Scale |
| BPSD |
Behavioural and Psychological Symptoms of Dementia |
| BWSQ |
Benzodiazepine Withdrawal Symptom Questionnaire |
| CAC |
Coronary Artery Calcium |
| CANMAT |
Canadian Network for Mood and Anxiety Treatments |
| CBR |
Consensus-Based Recommendation |
| CBT |
Cognitive Behavioural Therapy |
| CGM |
Continuous Glucose Monitoring |
| CI |
Confidence Interval |
| CKD |
Chronic Kidney Disease |
| COPD |
Chronic Obstructive Pulmonary Disease |
| CRP |
C-Reactive Protein |
| CT |
Computed Tomography |
| CTX |
C-Terminal Telopeptide |
| CV |
Cardiovascular |
| CVD |
Cardiovascular Disease |
| DANTON |
Discontinuation of ANtihypertensive Treatment in Older people with dementia living in a Nursing
home |
| DAPT |
Dual Antiplatelet Therapy |
| DBI |
Drug Burden Index |
| DBP |
Diastolic Blood Pressure |
| DCM |
Dementia Care Mapping |
| DISCUS |
Dyskinesia Identification System Condensed User Scale |
| DLB |
Dementia with Lewy Bodies |
| DXA |
Dual-Energy X-ray Absorptiometry |
| EBR |
Evidence-Based Recommendation |
| EF |
Ejection Fraction |
| ESR |
Erythrocyte Sedimentation Rate |
| FLEX |
Fracture Intervention Trial Long-Term Extension |
| FLOW |
Evaluate Renal Function with Semaglutide Once Weekly |
| FVC |
Forced Vital Capacity |
| GDG |
Guideline Development Group |
| GDMT |
Guideline-Directed Medical Therapy |
| GI |
Gastrointestinal |
| GINA |
Global Initiative for Asthma |
| GORD |
Gastro-Oesophageal Reflux Disease |
| GPS |
Good Practice Statement |
| GRADE |
Grading of Recommendations Assessment, Development and Evaluation |
| GSM |
Genitourinary Syndrome of Menopause |
| HFpEF |
Heart Failure with preserved Ejection Fraction |
| HFmrEF |
Heart Failure with mildly reduced Ejection Fraction |
| HFrEF |
Heart Failure with reduced Ejection Fraction |
| HR |
Hazard Ratio |
| ICS |
Inhaled Corticosteroids |
| INR |
International Normalised Ratio |
| IPSS |
International Prostate Symptom Score |
| IV |
Intravenous |
| LABA |
Long-Acting Beta-Agonist |
| LAMA |
Long-Acting Muscarinic Antagonist |
| LSC |
Least Significant Change |
| LUTS |
Lower Urinary Tract Symptoms |
| MACE |
Major Adverse Cardiovascular Event |
| MADRS |
Montgomery-Asberg Depression Rating Scale |
| mcg |
microgram |
| mg |
milligram |
| MD |
Mean Difference |
| MHT |
Menopausal Hormone Therapy |
| MI |
Myocardial Infarction |
| MMSE |
Mini-Mental State Examination |
| MRONJ |
Medication-Related Osteonecrosis of the Jaw |
| NHMRC |
National Health and Medical Research Council |
| NNT |
Number Needed to Treat |
| NPI |
Neuropsychiatric Inventory |
| NPI-NH |
Neuropsychiatric Inventory Nursing Home Version |
| NRS |
Numeric Rating Scale |
| NSAID |
Non-steroidal Anti-Inflammatory Drug |
| OAC |
Oral Anticoagulant |
| 25[OH]D |
25-hydroxyvitamin D |
| OR |
Odds Ratio |
| P1NP |
Procollagen Type 1 N Propeptide |
| PBS |
Pharmaceutical Benefits Scheme |
| PCI |
Percutaneous Coronary Intervention |
| PDD |
Parkinson's Disease Dementia |
| PIM |
Potentially Inappropriate Medicine |
| PPI |
Proton Pump Inhibitor |
| PREVENTABLE |
Pragmatic Evaluation of Events and Benefits of Lipid Lowering in Older Adults |
| PROMIS |
Patient-Reported Outcomes Measurement Information System |
| PSQI |
Pittsburgh Sleep Quality Index |
| QoL |
Quality of Life |
| QOLAD |
Quality of life in Alzheimer's Dementia |
| QUALID |
Quality of Life in Late Stage of Dementia score |
| QUALIDEM |
Quality of Life for People with Dementia |
| RA |
Rheumatoid Arthritis |
| RCT |
Randomised Controlled Trial |
| RLS |
Restless Legs Syndrome |
| RR |
Relative Risk |
| SAPT |
Single Antiplatelet Therapy |
| SBP |
Systolic Blood Pressure |
| SD |
Standard Deviation |
| SELECT |
Semaglutide Effects on Cardiovascular Outcomes in People with Overweight or Obesity |
| SIB |
Severe Impairment Battery |
| SMB |
Standardised Mean Difference |
| SNRI |
Serotonin-Norepinephrine Reuptake Inhibitors |
| SoF |
Summary of Findings |
| SSRI |
Selective Serotonin Reuptake Inhibitors |
| STALD |
Sheffield Test for Acquired Language Disorders |
| STAREE |
STAtins in Reducing Events in the Elderly |
| START |
Screening Tool to Alert to Right Treatment |
| SVT |
Supraventricular Tachycardia |
| TCA |
Tricyclic Antidepressants |
| TPV |
Total Prostatic Volume |
| TURP |
Transurethral Resection of the Prostate |
| UKPDS |
United Kingdom Prospective Diabetes Study |
| ULT |
Urate-Lowering Therapy |
| UPDRS |
Unified Parkinson's Disease Rating Scale |
| VADT |
Veterans Affairs Diabetes Trial |
